These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23485791)

  • 21. The self-controlled case series method for evaluating safety of vaccines.
    Hawken S; Wilson KR
    Med J Aust; 2012 Nov; 197(10):578-9. PubMed ID: 23163690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter to the Editor. Guillain-Barré Syndrome(GBS) after vaccination reported to the United States Vaccine Adverse Event Reporting System(VAERS) in 2004.
    Haber P; Slade B; Iskander J
    Vaccine; 2007 Nov; 25(48):8101. PubMed ID: 17933441
    [No Abstract]   [Full Text] [Related]  

  • 23. Guillain-Barré syndrome in children aged <15 years in Latin America and the Caribbean: baseline rates in the context of the influenza A (H1N1) pandemic.
    Landaverde JM; Danovaro-Holliday MC; Trumbo SP; Pacis-Tirso CL; Ruiz-Matus C
    J Infect Dis; 2010 Mar; 201(5):746-50. PubMed ID: 20102270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guillain-Barré syndrome after exposure to influenza virus.
    Lehmann HC; Hartung HP; Kieseier BC; Hughes RA
    Lancet Infect Dis; 2010 Sep; 10(9):643-51. PubMed ID: 20797646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Avoiding Guillan-Barré Syndrome following swine origin pandemic H1N1 2009 influenza vaccination.
    Eisen DP; McBryde ES
    J Infect Dis; 2009 Nov; 200(10):1627-8. PubMed ID: 19857155
    [No Abstract]   [Full Text] [Related]  

  • 27. Pandemic (H1N1) 2009 influenza.
    Polkinghorne B; Ward K; Totaro R
    N S W Public Health Bull; 2010; 21(1-2):41-2. PubMed ID: 21367344
    [No Abstract]   [Full Text] [Related]  

  • 28. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.
    Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M
    Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.
    Kim C; Rhie S; Suh M; Kang DR; Choi YJ; Bae GR; Choi YC; Jun BY; Lee JS
    Vaccine; 2015 Apr; 33(15):1815-23. PubMed ID: 25728315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review.
    Isai A; Durand J; Le Meur S; Hidalgo-Simon A; Kurz X
    Vaccine; 2012 Nov; 30(49):7123-9. PubMed ID: 23022149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.
    Tokars JI; Lewis P; DeStefano F; Wise M; Viray M; Morgan O; Gargiullo P; Vellozzi C
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):546-52. PubMed ID: 22407672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza pandemics--pregnancy, pathogenesis, and perinatal outcomes.
    Steinhoff MC; MacDonald NE
    JAMA; 2012 Jul; 308(2):184-5. PubMed ID: 22782421
    [No Abstract]   [Full Text] [Related]  

  • 33. What we know about influenza vaccine and Guillain-Barré syndrome.
    Enos L
    Oreg Nurse; 2009 Nov; ():5. PubMed ID: 19998739
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety of influenza vaccination: Risk-benefit evaluation.
    Wiwanitkit V
    Muscle Nerve; 2010 Aug; 42(2):296; author reply 296. PubMed ID: 20544931
    [No Abstract]   [Full Text] [Related]  

  • 35. Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System.
    Souayah N; Nasar A; Suri MF; Qureshi AI
    Vaccine; 2007 Jul; 25(29):5253-5. PubMed ID: 17560693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010.
    Yih WK; Lee GM; Lieu TA; Ball R; Kulldorff M; Rett M; Wahl PM; McMahill-Walraven CN; Platt R; Salmon DA
    Am J Epidemiol; 2012 Jun; 175(11):1120-8. PubMed ID: 22582207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of antibody response to Guillain-Barré syndrome-related gangliosides in mice and men after novel flu vaccination.
    Yuki N; Takahashi Y; Ihara T; Ito S; Nakajima T; Funakoshi K; Furukawa K; Kobayashi K; Odaka M
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):116-7. PubMed ID: 21084265
    [No Abstract]   [Full Text] [Related]  

  • 39. [Keypoints of the guideline for management of Guillain -Barré syndrome and Fisher syndrome, 2013].
    Sonoo M
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():394-9. PubMed ID: 26480731
    [No Abstract]   [Full Text] [Related]  

  • 40. [Guillain-Barré syndrome after exposure to influenza].
    Hartung HP; Keller-Stanislawski B; Hughes RA; Lehmann HC
    Nervenarzt; 2012 Jun; 83(6):714-30. PubMed ID: 22528062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.